Articles

Patients with hypercortisolemic Cushing disease possess a distinct class of hematopoietic progenitor cells leading to erythrocytosis

Division of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
Multidisciplinary Pituitary and Skull Base Tumor Center, Departments of Medicine and Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY
National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome
Department of Biomedical and Neuromotorial Sciences, Alma Mater Studiorum University, Bologna, Italy; Altius Institute for Biomedical Sciences, Seattle, WA
Altius Institute for Biomedical Sciences, Seattle, WA
Department of Cell, Developmental, and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY
Division of Hematology, Department of Medicine, University of Washington, Seattle, WA
Altius Institute for Biomedical Sciences, Seattle, WA, USA; Center for Integrated Biomedical Research, Campus Bio-medico, Rome
Vol. 108 No. 4 (2023): April, 2023 https://doi.org/10.3324/haematol.2021.280542